{
  "id": "clinical#screening_cues_0720970e",
  "content": "result of fluctuations in mood stability associated with the previous\ntreatment). The antidepressant discontinuation syndrome is based\nsolely on pharmacological factors and is not related to the reinforcing ef-\nfects of an antidepressant. Also, in the case of stimulant augmentation of\nan antidepressant, abrupt cessation may result in stimulant withdrawal\nsymptoms (see “Stimulant Withdrawal” in the chapter “Substance-\nRelated and Addictive Disorders”) rather than the antidepressant dis-\ncontinuation syndrome described here.\nPrevalence\nThe prevalence of antidepressant discontinuation syndrome is un-\nknown but is thought to vary according to the dosage prior to dis-\ncontinuation, the half-life and receptor-binding affinity of the\nmedication, and possibly the individual’s genetically influenced rate\nof metabolism for this medication.\nCourse and Development\nBecause longitudinal studies are lacking, little is known about the\nclinical course of antidepressant discontinuation syndrome. Symp-\ntoms appear to abate over time with very gradual dosage reductions.\nAfter an episode, some individuals may prefer to resume medication\nindefinitely if tolerated.\nDifferential Diagnosis\nThe differential diagnosis of antidepressant discontinuation syn-\ndrome includes anxiety and depressive disorders, substance use dis-\norders, and tolerance to medications.\nAnxiety and depressive disorders. Discontinuation symptoms of-\nten resemble symptoms of a persistent anxiety disorder or a return of",
  "metadata": {
    "source": "DSM-5",
    "url": "https://psychiatry.org/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "screening_cues",
      "referral",
      "management"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Screening Cues result of fluctuations in mood stability associated with the previous\ntreatment). The antidepressant discontinuation syndrome is based\nsolely on pharmacological factors and is not related to the reinforcing ef-\nfects of an antidepressant. Also, in the case of stimulant augmentation of\nan antidepressant, abrupt cessation may result in stimulant withdrawal\nsymptoms (see “Stimulant Withdrawal” in the chapter “Substance-\nRelated and Addictive Disorders”) rather than the antidepressant dis-\ncontinuation syndrome described here.\nPrevalence\nThe prevalence of antidepressant discontinuation syndrome is un-\nknown but is thought to vary according to the dosage prior to dis-\ncontinuation, the half-life and receptor-binding affinity of the\nmedication, and possibly the individual’s genetically influenced rate\nof metabolism for this medication.\nCourse and Development\nBecause longitudinal studies are lacking, little is known about the\nclinical course of antidepressant discontinuation syndrome. Symp-\ntoms appear to abate over time with very gradual dosage reductions.\nAfter an episode, some individuals may prefer to resume medication\nindefinitely if tolerated.\nDifferential Diagnosis\nThe differential diagnosis of antidepressant discontinuation syn-\ndrome includes anxiety and depressive disorders, substance use dis-\norders, and tolerance to medications.\nAnxiety and depressive disorders. Discontinuation symptoms of-\nten resemble symptoms of a persistent anxiety disorder or a return of Result of fluctuations in mood stability associated with the previous\ntreatment). the antidepressant discontinuation syndrome is based\nsolely on pharmacological factors and is not related to the reinforcing ef-\nfects of ..."
}